1977
DOI: 10.1056/nejm197706302962603
|View full text |Cite
|
Sign up to set email alerts
|

Theophylline Disposition in Patients with Hepatic Cirrhosis

Abstract: To determine the role of liver dysfunction in theophylline toxicity, we administered single intravenous doses of the drug to nine patients with cirrhosis and observed its disposition over a period of 24 to 48 hours. As compared to 19 normal subjects, these patients had a prolonged plasma half-life (mean, 25.6 vs. 6.7 hours) and a decreased plasma clearance (mean, 0.042 vs. 0.062 liter[kg-1]hr-1). Volumes of distribution of theophylline in the cirrhotic patients (central-compartment volume of 0.330, and steady-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
35
0

Year Published

1978
1978
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 189 publications
(40 citation statements)
references
References 11 publications
5
35
0
Order By: Relevance
“…Patients with hepatic cirrhosis be avoided. The therapeutic blood levels were have a prolonged plasma half-life; the mean found by Turner-Warwick (133) to be at a value in nine patients was found to be 25.6 h plasma concentration of 10-20 mg/1 and this (100). has been substantially corroborated by all later…”
mentioning
confidence: 71%
“…Patients with hepatic cirrhosis be avoided. The therapeutic blood levels were have a prolonged plasma half-life; the mean found by Turner-Warwick (133) to be at a value in nine patients was found to be 25.6 h plasma concentration of 10-20 mg/1 and this (100). has been substantially corroborated by all later…”
mentioning
confidence: 71%
“…While it has been suggested that passive congestion of the liver in patients with heart failure might alter the hepatic capacity to extract and metabolize theophylline (Piafsky et al, 1977b), this possibility has not been experimentally verified. Our observation that cor pulmonale, as well as pulmonary edema, reduces theophylline clearance would be compatible with this mechanism of decreased hepatic cleance, since cardiac output per se and possibly liver perfusion, are normal in cor pulmonale (Parker, Kelkar & West, 1966).…”
Section: Pooled Oral and Intravenous Resultsmentioning
confidence: 99%
“…High plasma concentrations are associated with gastrointestinal side effects and cardiac arrhythmias (Eaton et al, 1980). Theophylline is metabolized by the liver, and its metabolic rate is very sensitive to changes in hepatic function (Baselt & Albertson, 1982;Mangione et al, 1978;Piafsky et al, 1977a). The dose needs to be adjusted depending on the patient's history of smoking (Hunt et al, 1976;Jusko et al, 1978), heart disease (Piafsky et al, 1977b), liver disease (Baselt & Albertson, 1982;Mangione et al, 1978;Piafsky et al, 1977a), or acute viral illnesses (Chang et al, 1978).…”
Section: Arbaprostil (15(r)-15-methyl Pge2): Lack Of Effect On Theophmentioning
confidence: 99%
“…Theophylline is metabolized by the liver, and its metabolic rate is very sensitive to changes in hepatic function (Baselt & Albertson, 1982;Mangione et al, 1978;Piafsky et al, 1977a). The dose needs to be adjusted depending on the patient's history of smoking (Hunt et al, 1976;Jusko et al, 1978), heart disease (Piafsky et al, 1977b), liver disease (Baselt & Albertson, 1982;Mangione et al, 1978;Piafsky et al, 1977a), or acute viral illnesses (Chang et al, 1978). Theophylline's plasma clearance will be decreased by the concurrent administration of cimetidine or erythromycin (Conlon et al, 1981;Jackson et al, 1981;Landay et al, 1978;Prince et al, 1981;Renton et al, 1981;Roberts et al, 1981).…”
Section: Arbaprostil (15(r)-15-methyl Pge2): Lack Of Effect On Theophmentioning
confidence: 99%